175 related articles for article (PubMed ID: 8996492)
1. Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals.
Munschauer FE; Priore RL; Hens M; Castilone A
Stroke; 1997 Jan; 28(1):72-6. PubMed ID: 8996492
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.
Can J Cardiol; 1998 May; 14(5):695-702. PubMed ID: 9627526
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
4. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
[TBL] [Abstract][Full Text] [Related]
5. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
6. Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications.
Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Jacobs V; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27402230
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation and stroke prevention in the community.
O'Connell JE; Gray CS
Age Ageing; 1996 Jul; 25(4):307-9. PubMed ID: 8831876
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.
Verheugt FWA; Gao H; Al Mahmeed W; Ambrosio G; Angchaisuksiri P; Atar D; Bassand JP; Camm AJ; Cools F; Eikelboom J; Kayani G; Lim TW; Misselwitz F; Pieper KS; van Eickels M; Kakkar AK;
Eur Heart J; 2018 Feb; 39(6):464-473. PubMed ID: 29281086
[TBL] [Abstract][Full Text] [Related]
9. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
Yu HC; Tsai YF; Chen MC; Yeh CH
Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
[TBL] [Abstract][Full Text] [Related]
11. How to define valvular atrial fibrillation?
Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A
Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation: prevalence and management in an acute general medical unit.
Stewart FM; Singh Y; Persson S; Gamble GD; Braatvedt GD
Aust N Z J Med; 1999 Feb; 29(1):51-8. PubMed ID: 10200813
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
14. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
Ghaswalla PK; Harpe SE; Slattum PW
Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
[TBL] [Abstract][Full Text] [Related]
15. Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke.
Mendelson G; Aronow WS
J Am Geriatr Soc; 1998 Nov; 46(11):1423-4. PubMed ID: 9809766
[TBL] [Abstract][Full Text] [Related]
16. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
[TBL] [Abstract][Full Text] [Related]
17. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
18. The use of anticoagulants in the management of atrial fibrillation among general practices in England.
Cowan C; Healicon R; Robson I; Long WR; Barrett J; Fay M; Tyndall K; Gale CP
Heart; 2013 Aug; 99(16):1166-72. PubMed ID: 23393083
[TBL] [Abstract][Full Text] [Related]
19. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
20. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
